MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.

P. Douschan (Graz, Austria), V. Foris (Graz, Austria), A. Avian (Graz, Austria), T. Sassmann (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria)

Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Session: Exercise and haemodynamics in pulmonary hypertension
Session type: E-poster session
Number: 1508
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Douschan (Graz, Austria), V. Foris (Graz, Austria), A. Avian (Graz, Austria), T. Sassmann (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria). MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.. 1508

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
emPHasis-10 score predicts mortality in patients with pulmonary hypertension
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018



Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012


Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020

Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Arterial hypertension and the risk of severity and mortality of COVID-19
Source: Eur Respir J, 55 (6) 2001148; 10.1183/13993003.01148-2020
Year: 2020



Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021



Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011


Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Non-invasive mortality predictors in pediatric pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010


The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012



Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Age, risk and outcomes in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018
Year: 2018



Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009